Comparative Analysis of Prognostic Potential of Pretreatment Blood-Based Biomarkers in Metastatic Bladder Cancer: Modified Glasgow Prognostic Score.

J Clin Med · 2025 · PMC11942973 · PMID 40142762

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Other biomarkers, including the Bellmunt score (HR = 1.064, 95% CI: 0.71–1.6, p = 0.76), systemic immune-inflammation index (SII) (HR = 2.170, 95% CI: 0.55–8.6, p = 0.27), neutrophil-to-lymphocyte ratio (NLR) (HR = 1.530, 95% CI: 0.37–6.4, p = 0.56), and prognostic nutritional index (PNI) (HR = 1.001, 95% CI: 0.99–1.008, p = 0.87), did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.